Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)
Clinical trial NCT06859684 · RECRUITING
Trial details
- NCT number
- NCT06859684
- Sponsor
- West China Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-01
- Primary completion
- 2026-09-06
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.